Crenae Therapeutics
Biotechnology - Phoenix, Arizona, United States
Crenae Therapeutics Employees
Crenae Therapeutics Senior Management
Crenae Therapeutics Details
Crenae Therapeutics is focused on the development of anti-ASPH therapeutics for the treatment of metastatic cancer. ASPH inhibitors are non-toxic, orally bioavailable, Notch pathway modulators without dose limiting GI toxicity like previous Notch therapeutics. A robust IP portfolio, including small molecules, antibody diagnostics and therapeutics, and backup chemotypes provides a strong IP foundation for developing anti-ASPH therapeutics. Target cancers include veterinary, human orphan cancers such as cholangiocarcinoma and fibrolamellar hepatocellular carcinoma, and large market cancers including lung, hepatocellular carcinoma, breast, pancreatic, gastric and colon cancers.
Crenae Therapeutics Technologies
Captcha
reCAPTCHA
Load Balancers
Apache
Fonts
Google Font API
Advertising Networks
Google AdSense
Other
Mobile Friendly
Analytics and Tracking
Google Analytics